Spruce Biosciences Stock (NASDAQ: SPRB) stock price, news, charts, stock research, profile.
You can purchase shares of Spruce Biosciences (NASDAQ:SPRB) through any online brokerage.
Other companies in Spruce Biosciences’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP), CARISMA Therapeutics (NASDAQ:CARM) and Imunon (NASDAQ:IMNN).
Spruce Biosciences has a consensus price target of $3.90.
The stock price for Spruce Biosciences (NASDAQ: SPRB) is $0.42 last updated December 24, 2024 at 4:59 PM EST.
There are no upcoming dividends for Spruce Biosciences.
Spruce Biosciences’s Q4 earnings are confirmed for Wednesday, March 12, 2025.
There is no upcoming split for Spruce Biosciences.
Spruce Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.